OneMedNet Corporation (NASDAQ:ONMD – Get Free Report) Director Thomas Kosasa bought 129,758 shares of OneMedNet stock in a transaction that occurred on Wednesday, October 7th. The stock was purchased at an average cost of $5.78 per share, for a total transaction of $750,001.24. Following the acquisition, the director owned 1,983,573 shares of the company’s stock, valued at $11,465,051.94. This represents a 7.00% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.
Thomas Kosasa also recently made the following trade(s):
- On Thursday, July 30th, Thomas Kosasa purchased 144,927 shares of OneMedNet stock. The stock was purchased at an average price of $6.90 per share, with a total value of $999,996.30.
OneMedNet Trading Up 17.2%
NASDAQ ONMD opened at $4.71 on Thursday. OneMedNet Corporation has a 52 week low of $3.61 and a 52 week high of $31.00. The firm has a 50 day moving average of $6.07 and a two-hundred day moving average of $7.22.
Analyst Ratings Changes
Read Our Latest Stock Report on OneMedNet
OneMedNet Company Profile
OneMedNet Corporation is a healthcare technology company that develops infrastructure for accessing, managing and analyzing medical data. Its platform is designed to help healthcare providers, researchers, life sciences companies and other authorized users work with clinical and medical-imaging information while keeping the underlying data within the organization that controls it.
The company’s technology uses a federated data model, allowing participating institutions to collaborate on data analysis without routinely transferring sensitive patient information to a centralized repository.
Recommended Stories
- Five stocks we like better than OneMedNet
- Tesla Wants to Make Its Own Chips—What Could Go Wrong?
- IREN Limited’s AI Pivot Gains Traction—But Can Its Data Centers Deliver?
- PBF Energy’s Stunning Rally Faces a Critical Test
- Citi Stock Falls Despite Earnings Beat: What Investors Need to Know
Receive News & Ratings for OneMedNet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OneMedNet and related companies with MarketBeat.com's FREE daily email newsletter.
